Abstract
Objective:
Quantitative evaluation of the effect of exercise intervention in amyotrophic lateral sclerosis (ALS).
Methods:
The CNKI, WOS, PubMed, and Scopus databases were searched by computer, and randomized controlled trials (RCTs) of exercise intervention in ALS were screened out according to the inclusion and exclusion criteria of the PICOS principle. Stata 12.0 software was used for statistical analysis.
Results:
A total of 12 RCTs including 430 participants were included. Meta-analysis results show that exercise intervention can significantly improve the overall function, walking test (WT) distance and maximum expiratory pressure (MEP) of ALS patients (p < 0.05). However, exercise interventions did not show significant effects on fatigue, maximum inspiratory pressure (MIP), forced vital capacity (FVC), and peak expiratory flow (PEF) in ALS patients (p > 0.05). Subgroup analysis showed that resistance exercise is the most effective intervention for improving the function of ALS patients, while aerobic exercise is the most effective intervention for improving FVC in ALS patients.
Conclusion:
Exercise intervention in ALS has a positive effect, but due to the small number of included studies and possible heterogeneity, risk of bias and sensitivity issues, further research is needed.
1 Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive, lethal motor neuron disease. It usually involves upper motor neurons (brain, brainstem, spinal cord) and lower motor neurons (cranial nerve nuclei, anterior horn cells of the spinal cord) and manifests mainly as muscle weakness, atrophy, dysarthria and dysphagia (1, 2). ALS most often develops between the ages of 50 and 60 and most patients die within 3–5 years from respiratory paralysis or lung infection (3).
Although ALS is still a disease that cannot be completely cured at present, there are many ways to improve patients’ quality of life and slow down disease progression, such as nutritional management (4), assisted breathing (5), psychotherapy (6) and medication (7). However, the aforementioned strategies may have some limitations, such as being highly passive, causing side effects, and having limited functional improvement (1, 8). For example, assisted ventilation typically relies on devices such as ventilators to help patients breathe, which restricts their range of activities and independence in daily life (1). In addition, pharmacological treatments often come with side effects such as nausea, vomiting, and dizziness, and long-term use may potentially cause damage to liver and kidney functions (9). Moreover, the above treatments mainly focus on alleviating local symptoms in ALS patients. For instance, nutritional management emphasizes providing the necessary material basis for the body, assisted ventilation targets only respiratory function support, and psychological therapy primarily aims to adjust the patient’s psychological state and alleviate emotional issues to improve quality of life. However, these approaches have insufficient impact on enhancing the patients’ overall physical condition, improving daily physiological functions, and ultimately, on improving quality of life.
As research continues to advance, moderate exercise tailored to the patient’s disease stage and physical condition is considered beneficial for ALS patients (10). For example, strength exercises to slow down weakness, flexibility exercises to reduce contractures, and prolonged activities such as walking to maintain endurance (11). Patients with ALS are often physically weak and frequently experience complications such as muscle atrophy, muscle spasms, respiratory difficulties, and sensory abnormalities (12, 13). Therefore, traditional medical advice for ALS patients usually emphasizes avoidance of exercise to prevent injury and exacerbation of the condition due to exercise (14, 15). However, most studies (16, 17) recommend that patients with neuromuscular diseases engage in moderate exercise tailored to their condition to maintain physical function and improve quality of life. The reason is that increasing the content of mitochondria in the muscles can enhance blood flow to the muscles, thereby maintaining and enhancing muscle strength, which in turn helps to maintain their ability to perform daily activities (16, 17). Therefore, the results of current studies on the effects of exercise on ALS patients and the relationship between the two are inconsistent. In addition, studies by Kilmer (14) and Francis et al. (18) have concluded that the effect of exercise on ALS patients is controversial.
In fact, studies (19–21) have already used systematic reviews and meta-analyses to explore the effects of exercise interventions on ALS. However, these studies included a variety of exercise types, such as aerobic exercise, resistance exercise, combined exercise, and respiratory muscle training. Yet, they fell short in investigating which type of exercise is more beneficial for ALS patients. In other words, the relationship between exercise type and outcome measures is unclear, and it is uncertain which type of exercise can better promote the improvement of specific indicators. Therefore, they are unable to provide a more precise exercise guideline for ALS patients. Therefore, this study systematically searched for studies related to exercise interventions for ALS, and explored the effects of exercise interventions for ALS through systematic review and meta-analysis. Additionally, subgroup analyses were conducted to explore the effects of different types of exercise interventions and to clarify the associations between exercise types and outcome measures in ALS patients. This study is used to facilitate health care workers to understand the risks and benefits of exercise in order to develop a safe and appropriate exercise plan.
2 Methods
The study was written and reported in strict accordance with the PRISMA 2020 entry list (22) for the search strategy, selection criteria, data extraction, bias assessment and mathematical statistics.
2.1 Search strategy
One researcher conducted the relevant literature search in English and Chinese. The search terms “amyotrophic lateral sclerosis (ALS),” “motor neuron disease (MND)” and “Lou Gehrig” were combined with “sport,” “exercise,” “training” and “fitness” in CNKI, Web of Science (WOS), PubMed and Scopus. The search time frame is from the creation of this database to November 2022.
2.2 Selection criteria
This study was designed with inclusion and exclusion criteria based on the PICOS principles (23). Inclusion criteria: (1) The subjects were patients with ALS; (2) The trial measures were any forms of exercise intervention; (3) The control measures included daily activities, usual care, stretching exercises, neuro-rehabilitation therapy and placebo exercise; (4) The outcome variables included at least one of ALS function, fatigue, WT (walk test), MIP (maximum inspiratory pressure), MEP (maximum expiratory pressure), FVC (forced vital capacity), PEF (peak expiratory flow rate); (5) The study design was a randomized controlled trial (RCT). Exclusion criteria: (1) Animal experiments, case reports, single-group experiments, quasi-experimental designs; (2) Positive controls in multi-arm studies; (3) Reviews, abstracts, letters, commentaries; (4) Incomplete data information on outcome variables; (5) Combined interventions that include exercise, such as the combination of exercise and nutrition; (6) Repeated publications for the same subjects, including only literature of relatively high quality. The selection process follows the order of title, abstract, figure, and full text. The literature was screened by two researchers independently according to the selection criteria, and the screened literature was secondarily assessed by two other researchers, and if there was a dispute, it was mutually agreed in a group discussion.
2.3 Data extraction
The data extract includes the first author, publication date, study design, participant characteristics, exercise protocol and outcome variables. For this study, the extracts were entered into Excel 2010 and saved. The data extraction was carried out independently by two researchers, and the extraction was secondarily assessed by two other researchers, and if there were controversial issues, a group discussion was held to decide jointly.
2.4 Quality assessment
This study used the risk of bias assessment tool recommended by the Cochrane Collaboration Network (24, 25) to assess the risk of bias for RCTs. The tool assesses six aspects of random methods, blinding, allocation concealment, completeness of outcome data, selective reporting of findings and other biases. Two researchers judged independently on the basis of the assessment tool, and where there were serious disagreements, the entries were discussed with a third researcher.
2.5 Data analysis
This study used Stata 12.0 software for data processing and statistical analysis. The models were selected by heterogeneity tests to test for combined effects. The Q-test and I2 statistic were used to test for between-study heterogeneity. If I2 < 50% and p > 0.1, the between-study heterogeneity was considered small and a fixed-effects model was selected for analysis; if I2 ≥ 50% and p ≤ 0.1, the between-study heterogeneity was considered large and a random-effects model was selected for analysis. This study explores the effects of different exercise types on ALS through subgroup analysis. This study explored the sources of heterogeneity through one-way meta-regression analysis. The study was tested for publication bias through Egger linear regression analysis. Sensitivity analysis was conducted using the “metainf” command for the one-by-one elimination method. Effect sizes for continuous variable information are expressed using standardized mean differences (SMD) and 95% confidence intervals (CI) are used to express the estimated intervals of the overall parameters constructed from the sample statistics. The level of heterogeneity was set at α = 0.1 and the rest of the tests at α = 0.05.
3 Results
3.1 Selection results
In this study, 238 documents were retrieved, including 20 Chinese documents and 218 English documents. The retrieved literature was imported into EndNote X9 software for de-duplication, resulting in 160 documents. A total of 12 documents were selected for inclusion. The literature screening process is shown in Figure 1.
Figure 1

Flow chart for literature screening.
3.2 Data extraction results
Publication dates for the included studies were 2001 (26) to 2021 (27). A total of 430 participants were included in the meta-analysis to explore the effects of exercise interventions to improve ALS, including 222 in the test group and 208 in the control group. The mean age of the test group was 50.7 (28) ~ 63.2 (11) years old and the mean age of the control group was 53.4 (29) ~ 62.1 (30) years old. The proportion of females in the test group was 25.0% (11, 28) ~ 61.1% (27) and 25.0% (28) ~53.3% (30) of females in the control group. Participants were obtained from eight countries: Canada (31), Israeli (26, 27), Italy (32, 33), Australia (28, 29), United Kingdom (34), United States (30, 35), Portugal (11), and the Netherlands (36), of which studies with samples of ALS patients from Israel, Italy, Australia, and the United States included two each. Six studies (11, 26, 31–33) used the ALS Functional Scale (ALSFRS) as the standard for clinical judgment of ALS patients; five studies (27, 28, 30, 35, 36) based the diagnosis on the revised El-Escorial criteria; and the remaining one study (29) only indicated that the enrolled ALS patients had a clinical diagnosis, without mentioning the specific criteria. The exercise intervention program in the test group consisted of four types of aerobic exercise (11), resistance exercise (26, 31, 33), combined exercise (27, 28, 32, 36), and respiratory muscle training (29, 30, 34, 35). The exercise period was 5 weeks (32) ~52 weeks (26), the frequency of exercise was 2 times/week (26, 34) ~21 times/week (29), and the duration of each session was 10 min (29, 34) ~60 min (32). The participants in the control group mainly performed stretching exercises (27, 31), daily activities (26, 28), nursing training (11), and so on. All included studies collected relevant data immediately after the intervention. Among them, 11 studies (11, 26–28, 30–36) assessed the ALS function of the participants; 6 studies (26, 27, 31, 32, 34, 36) evaluated the fatigue level of the participants; 2 studies (27, 32) assessed the walking ability of the participants; 3 studies (27, 29, 34) evaluated the maximum inspiratory pressure of the participants; 7 studies (11, 27, 29, 33–36) assessed the forced vital capacity of the participants; 2 studies (34, 35) evaluated the peak expiratory flow rate of the participants; 2 studies (27, 35) assessed the maximum expiratory pressure of the participants. In addition, no studies reported adverse reactions among the participants. The basic characteristics of the included studies are shown in Table 1.
Table 1
| Included studies | Subject characteristics (n/ age/ F%/ nationality/ clinical information) | Exercise protocol | Outcome variables | ||||
|---|---|---|---|---|---|---|---|
| TG | CG | TG | CG | Time points | Variables | Adverse reactions | |
| Bello-Haas et al. (2007) (31) |
n = 11 Age = N/A F% = N/A Canada ALSFRS≥30 |
n = 14 Age = N/A F% = N/A Canada ALSFRS≥30 |
6 months resistance exercise + stretching (3 times/day) | Stretching exercises (1 time/day) | Immediately after the intervention | ①② | No |
| Drory et al. (2001) (26) |
n = 14 Age = 60 (41 ~ 80) F% = 42.9% Israeli Mean ALSFRS = 27.5 |
n = 11 Age = 60 (41 ~ 80) F% = 45.5% Israeli Mean ALSFRS = 27.5 |
12 months moderate intensity muscle workout (2 times/day, 15 min/time) | Daily activities | Immediately after the intervention | ①② | No |
| Merico et al. (2018) (32) |
n = 23 Age = 61.6 ± 10.6 F% = 43.5% Italy Mean ALSFRS = 36.1 ± 4.71 |
n = 15 Age = 59.8 ± 14.7 F% = 26.7% Italy Mean ALSFRS = 34.5 ± 3.6 |
5 weeks aerobic exercise (65% HRmax, 5 times/week, 15-20 min/time) combined with resistance exercise (3 repetitions, 30s interval) for 1 h | Neuro-motor rehabilitation | Immediately after the intervention | ①②③ | No |
| Cheah et al. (2009) (29) |
n = 9 Age = 54.2 ± 9.8 F% = 33.3% Australia Clinical diagnosis |
n = 10 Age = 53.4 ± 9.5 F% = 40.0% Australia Clinical diagnosis |
12 weeks IMT (15 to 60% SNIP, 7 days/week, 3 times/day, 10 min/time) | Placebo | Immediately after the intervention | ④⑤ | No |
| Pinto et al. (2012) (34) |
n = 13 Age = 57.1 ± 9.3 F% = 46.2% United Kingdom ALSFRS = 24/40 |
n = 13 Age = 56.8 ± 8.7 F% = 15.4% United Kingdom ALSFRS = 24/40 |
8 months IMT (30% MIP, 2 times/day, 10 min/time) | Placebo | Immediately after the intervention | ①②④⑤⑥ | No |
| Plowman et al. (2016) (30) |
n = 25 Age = 62.2 ± 10.5 F% = 44.0% United States Diagnosis based on the revised El-Escorial criteria |
n = 15 Age = 62.1 ± 13.2 F% = 53.3% United States Diagnosis based on the revised El-Escorial criteria |
5 weeks EMST (50% MEP, 5 days/week, 20 min/day) | Placebo | Immediately after the intervention | ① | No |
| Plowman et al. (2019) (35) |
n = 24 Age = 63.1 ± 10.1 F% = 29.2% United States Diagnosis based on the revised El-Escorial criteria |
n = 24 Age = 60.1 ± 10.3 F% = 50.0% United States Diagnosis based on the revised El-Escorial criteria |
8 weeks EMST (50% MEP, 5 days/week, 20 min/day) | Placebo | Immediately after the intervention | ①⑤⑥⑦ | No |
| Lunetta et al. (2016) (33) |
n = 30 Age = 61.1 ± 10.1 F% = 30.0% Italy ALSFRS-R = 39.1 ± 4.7 |
n = 30 Age = 60.3 ± 9.9 F% = 43.3% Italy ALSFRS-R = 38.3 ± 5.1 |
6 months resistance exercise (60% MPO, 3 reps/set for 20 min) | Routine care | Immediately after the intervention | ①⑤ | No |
| Braga et al. (2018) (11) |
n = 24 Age = 63.2 ± 13.0 F% = 25.0% Portugal ALSFRS-R ≥ 30 |
n = 24 Age = 62.0 ± 12.1 F% = 41.0% Portugal ALSFRS-R ≥ 30 |
6 months moderate intensity aerobic exercise (20% CEPT, 2 times/week) + nursing training (exercise routine and gait exercises) | Nursing training (exercise routine and gait exercises) | Immediately after the intervention | ①⑤ | No |
| van Groenestijn et al. (2019) (36) |
n = 27 Age = 60.9 ± 10.0 F% = 33.0% Netherlands Diagnosis based on the revised El-Escorial criteria |
n = 27 Age = 59.9 ± 10.7 F% = 27.0% Netherlands Diagnosis based on the revised El-Escorial criteria |
16 weeks of aerobic exercise (50–75% HRR, 4 times/week, 30 min/time) + strength exercises (40–50% 1RM, 20 min) | Neuro-palliative care | Immediately after the intervention | ①②⑤ | No |
| Ferri et al. (2019) (28) |
n = 8 Age = 50.7 ± 3.3 F% = 25.0% Australia Diagnosis based on the revised El-Escorial criteria |
n = 8 Age = 55.5 ± 6.0 F% = 25.0% Australia Diagnosis based on the revised El-Escorial criteria |
12 weeks of exercise (3 times/week, 60 min/time, 15 min cardio + 20 min resistance + 10 min balance + 10 min stretching exercises) | Daily activities | Immediately after the intervention | ① | No |
| Kalron et al. (2021) (27) |
n = 14 Age = 58.5 ± 13.2 F% = 61.1% Israeli Diagnosis based on the revised El-Escorial criteria |
n = 14 Age = 56.7 ± 11.8 F% = 42.9% Israeli Diagnosis based on the revised El-Escorial criteria |
12 weeks aerobic exercise (40–60% HRR, 20-30 min) + passive stretching (10 min) + self-weight exercises (20 min), 2 times/week for 50-60 min | Passive stretching activities (5 times/week, 20 min/time) | Immediately after the intervention | ①②③④⑤⑦ | No |
Basic characteristics of the included documents.
n, sample size; F%, proportion of females; TG, test group; CG, control group; N/A, not reported or unclear; ① = ALSFRS (ALS Functional Scale)/FIM (Functional Independence Measure); ② = FSS (Fatigue Severity Scale)/CIS-Fatigue (Checklist Individual Strength-Fatigue); ③ = WT (Walk Test); ④ = MIP (maximum inspiratory pressure); ⑤ = FVC (forced vital capacity); ⑥ = PEF (peak expiratory flow rate); ⑦ = MEP (maximum expiratory pressure); IMT, inspiratory muscle training; EMST, expiratory muscle training; HRmax, maximum heart rate; SNIP, sniff nasal inspiratory pressure; MIP, maximum inspiratory pressure; MEP, maximum expiratory pressure; MPO, maximum power output. CPET, cardio pulmonary exercise testing; HRR, heart rate reserve; 1RM, 1 repetition maximum force.
3.3 Quality assessment results
The majority of included studies reported blinded methods, there was no selective reporting of study results, and it is unclear whether other biases existed. However, most studies did not report methods of randomization and allocation concealment, and most studies had ALS patient dropouts. The primary reason for ALS patients to discontinue exercise is due to physical discomfort caused by disease progression. ALS is a progressive neurodegenerative disease. As the condition worsens, patients experience increasing muscle weakness and atrophy, which may rapidly render them unable to perform exercises they were previously capable of. Moreover, exercise increases the body’s demand for oxygen. Given that patients may have insufficient respiratory function, they could experience dyspnea and shortness of breath during exercise. These symptoms can severely impact the exercise experience and even pose a threat to life, thereby forcing them to stop exercising. The results of the quality assessment of the included studies are shown in Table 2.
Table 2
| Included studies | Random methods | Blinding | Allocation concealment | Completeness of outcome data | Selective reporting of findings | Other biases |
|---|---|---|---|---|---|---|
| Bello-Haas et al. (2007) (31) | Unclear | Single blind | Sealed envelope | 9 cases withdrawn | No | Unclear |
| Drory et al. (2001) (26) | Unclear | Unclear | Unclear | 7 cases withdrawn | No | Unclear |
| Merico et al. (2018) (32) | Unclear | Single blind | Unclear | Complete | No | Unclear |
| Cheah et al. (2009) (29) | Arrange the arrays randomly | Double blind | Sealed envelope | 1 cases withdrawn | No | Unclear |
| Pinto et al. (2012) (34) | Unclear | Double blind | Unclear | 4 cases withdrawn | No | Unclear |
| Plowman et al. (2016) (30) | Unclear | Single blind | Unclear | 4 cases withdrawn | No | Unclear |
| Plowman et al. (2019) (35) | Arrange the arrays randomly | Double blind | Unclear | 2 cases withdrawn | No | Unclear |
| Lunetta et al. (2016) (33) | Unclear | Single blind | Unclear | 4 cases withdrawn | No | Unclear |
| Braga et al. (2018) (11) | Arrange the arrays randomly | Single blind | Unclear | Complete | No | Unclear |
| van Groenestijn et al. (2019) (36) | Minimize Random | Single blind | Unclear | 17 cases withdrawn | No | Unclear |
| Ferri et al. (2019) (28) | Unclear | Unclear | Unclear | 5 cases withdrawn | No | Unclear |
| Kalron et al. (2021) (27) | Unclear | Single blind | Sealed envelope | 4 cases withdrawn | No | Unclear |
Results of the quality assessment of the included studies.
3.4 Meta-analysis results
The results of the heterogeneity test (Table 3) showed that there was a large heterogeneity in ALS function, fatigue, FVC and PEF (I2 > 50%, p < 0.1), so the random effects model was used for the main effects test; WT, MIP and MEP had lower heterogeneity (I2 < 50%, p > 0.1), so the fixed effects model was used for the main effects test. The results of the main effects test (Table 3) showed that the exercise intervention significantly improved the function of ALS patients [SMD = 0.499, 95% CI = (0.055, 0.943), Z = 2.20, p = 0.028], increased the distance of WT [SMD = 0.967, 95% CI = (0.448, 1.487), Z = 3.65, p = 0.000], and increased MEP [SMD = 0.500, 95% CI = (0.043, 0.957), Z = 2.14, p = 0.032]. However, for fatigue, MIP, FVC, and PEF, the effects of exercise intervention were poor (p > 0.05). The meta-analysis results of exercise intervention for ALS are detailed in Supplementary material 1.
Table 3
| Outcome variables | N | Heterogeneity test | Main effects test | ||||
|---|---|---|---|---|---|---|---|
| I2 | p | Z | p | SMD | 95% CI | ||
| ALS Function | 11 | 77.0% | 0.000 | 2.20 | 0.028 | 0.499 | (0.055, 0.943) |
| Fatigue | 6 | 92.1% | 0.000 | 0.72 | 0.474 | 0.412 | (−0.717, 1.542) |
| WT | 2 | 11.0% | 0.289 | 3.65 | 0.000 | 0.967 | (0.448, 1.487) |
| MIP | 3 | 24.1% | 0.268 | 0.74 | 0.461 | 0.175 | (−0.290, 0.639) |
| MEP | 2 | 0.0% | 0.850 | 2.14 | 0.032 | 0.500 | (0.043, 0.957) |
| FVC | 7 | 80.3% | 0.000 | 1.19 | 0.233 | 0.337 | (−0.216, 0.889) |
| PEF | 2 | 57.7% | 0.124 | 0.58 | 0.565 | 0.216 | (−0.519, 0.950) |
Meta-analysis of the effects of exercise intervention for ALS.
N indicates the number of studies included; ALS is amyotrophic lateral sclerosis; WT is the walk test; MIP is maximum inspiratory pressure; MEP is maximum expiratory pressure; FVC is forced vital capacity; PEF is peak expiratory flow rate.
3.5 Subgroup analysis
Due to the relative paucity of included studies in WT, MIP, MEP and PEF, subgroup analyses were not invariably performed, so this study investigated the effect of different exercise types on the intervention of ALS using ALS function, fatigue and FVC as dependent variables and exercise type as independent variables, respectively. The results of the heterogeneity test (Table 4) showed that there was a large heterogeneity in the studies of combined exercise interventions for ALS function (I2 > 50%, p < 0.1), which were analyzed using a random effects model; the remaining studies of exercise intervention outcome variables had a lower heterogeneity (I2 < 50%, p > 0.1), so they were all analyzed using a fixed effects model. Both aerobic and resistance exercise were able to significantly improve the function of ALS patients (p < 0.05), with resistance exercise having the largest effect size (SMD = 0.686), while combined exercise and respiratory muscle training were not effective interventions for the function of ALS patients (p > 0.05). The effects of resistance exercise, combined exercise, and respiratory muscle training on alleviating fatigue in ALS patients were not significant (p > 0.05). Aerobic exercise significantly improved FVC in ALS patients (p < 0.05), while resistance exercise, combined exercise and respiratory muscle training were not effective interventions for FVC in ALS patients (p > 0.05). The subgroup analysis results of exercise intervention for ALS are detailed in Supplementary material 2.
Table 4
| Outcome variables | Subgroup | N | Heterogeneity test | Main effects test | ||||
|---|---|---|---|---|---|---|---|---|
| I2 | p | Z | p | SMD | 95% CI | |||
| ALS Function | Aerobic exercise | 1 | — | — | 2.13 | 0.034 | 0.629 | (0.049, 1.209) |
| Resistance exercise | 3 | 0.0% | 0.696 | 3.47 | 0.001 | 0.686 | (0.299, 1.073) | |
| Combined exercise | 4 | 91.1% | 0.000 | 1.82 | 0.069 | 1.335 | (−0.105, 2.776) | |
| Respiratory muscle training | 3 | 0.0% | 0.626 | 0.22 | 0.826 | −0.042 | (−0.414, 0.330) | |
| Fatigue | Resistance exercise | 2 | 52.1% | 0.149 | 1.21 | 0.225 | −0.515 | (−1.345, 0.316) |
| Combined exercise | 3 | 96.0% | 0.000 | 1.27 | 0.204 | 1.485 | (−1.808, 3.779) | |
| Respiratory muscle training | 1 | — | — | 1.56 | 0.119 | −0.627 | (−1.416, 0.162) | |
| FVC | Aerobic exercise | 1 | — | — | 5.54 | 0.000 | 1.961 | (1.268, 2.654) |
| Resistance exercise | 1 | — | — | 1.41 | 0.158 | 0.368 | (−0.143, 0.878) | |
| Combined exercise | 2 | 0.0% | 0.344 | 1.14 | 0.256 | −0.248 | (−0.677, 0.180) | |
| Respiratory muscle training | 3 | 0.0% | 0.828 | 0.54 | 0.590 | 0.112 | (−0.295, 0.519) | |
Subgroup analysis of the effect of different exercise types on ALS.
N indicates the number of studies included; ALS is amyotrophic lateral sclerosis; FVC is forced vital capacity.
3.6 Sources of heterogeneity
The results of the heterogeneity test showed that there is still a large heterogeneity among the included studies, so the sources of heterogeneity among the included studies remain to be explored. In this study, the effect size of ALS function was used as the dependent variable, and the study characteristics such as publication date, sample size, age of subjects, proportion of females, nationality of subjects, types of exercise, intervention period, frequency of intervention, and duration of exercise were coded as independent variables, and the sources of heterogeneity were explored by univariate meta-regression analysis. The results (Table 5) show that the underlying characteristic variables of the included studies were not a source of heterogeneity between studies of ALS function (p > 0.05), and the age of the subjects (t = −0.23, p = 0.051) reached borderline significant effects and may be a source of heterogeneity between included studies. However, more heterogeneity is not the result of a single factor, but may be the result of multiple factors acting together.
Table 5
| Study characteristics | β | SE | t | p | 95% CI |
|---|---|---|---|---|---|
| Publication date | −0.023 | 0.055 | −0.04 | 0.689 | (−0.148, 0.102) |
| Sample size | −0.053 | 0.044 | −0.12 | 0.262 | (−0.154, 0.047) |
| Age of subjects | −0.394 | 0.171 | −2.3 | 0.051 | (−0.788, 0.001) |
| Proportion of females | 0.001 | 0.037 | 0.04 | 0.972 | (−0.084, 0.087) |
| Nationality of subjects | 0.267 | 0.366 | 0.73 | 0.485 | (−0.562, 1.096) |
| Types of exercise | −0.270 | 0.259 | −1.04 | 0.325 | (−0.856, 0.317) |
| Intervention period | 0.015 | 0.024 | 0.64 | 0.541 | (−0.039, 0.069) |
| Frequency of intervention | −0.000 | 0.082 | −0.00 | 0.997 | (−0.186, 0.185) |
| Duration of exercise | 0.022 | 0.022 | 1.00 | 0.352 | (−0.031, 0.076) |
Results of one-way meta-regression analysis.
3.7 Publication bias test
The reliability of the results of the meta-analysis depends on the presence of bias in the included studies. This study used Egger linear regression for publication bias test. Egger linear regression is a quantitative test for the presence of publication bias to compensate for the lack of subjective judgments in funnel plots (37). The Egger linear regression model constructs a linear regression equation with the effect size as the dependent variable and the precision of the effect estimate as the independent variable, and the intercept of the regression equation is the offset, and the closer it is to 0, the less likely there is publication bias, and if p > 0.05 and the 95% CI contains 0, then there is no publication bias (37). Given the relatively few studies included in WT, MIP, MEP, and PEF, it was inconvenient to perform publication bias tests, so only Egger linear regression analyses were performed for ALS function, fatigue, and FVC. The results (Table 6) showed that p < 0.05 and 95% CI included 0 for ALS function, indicating the possibility of publication bias in the included studies; fatigue and FVC p > 0.05 and 95% CI included 0, indicating the absence of publication bias in the included studies.
Table 6
| Outcome variables | β | SE | t | p | 95% CI |
|---|---|---|---|---|---|
| ALS Function | 5.317 | 1.287 | 4.13 | 0.003 | (2.406, 8.227) |
| Fatigue | 6.444 | 5.581 | 1.15 | 0.313 | (−0.905, 21.939) |
| FVC | 3.022 | 4.624 | 0.65 | 0.542 | (−8.864, 14.907) |
Egger linear regression publication bias test.
ALS is amyotrophic lateral sclerosis; FVC is forced vital capacity.
3.8 Sensitivity analysis
Sensitivity analysis is an important method used in meta-analysis to assess the robustness and reliability of the combined results and to assess whether the combined results have been significantly changed by the influence of a particular study. In this study, a combined effects test was performed by excluding each study with the help of the “metainf” command, and the estimated range of the SMD for ALS function was found to be −0.256 ~ 10.629, the estimated range of the lower 95% CI was −0.898 ~ 6.572, and the estimated range of the upper 95% CI was 0.202 ~ 14.686, so there may be sensitivity issues with inclusion in the study. In this study, by retrospectively included studies, the studies that caused instability in the combined results were found to be Plowman and Watts et al. (30), Plowman and Tabor-Gray et al. (35) and van Groenestijn et al. (36). After excluding three papers, the results of the combined effects test were similar to those of the main effects test and the results were relatively stable.
4 Discussion
The results of the meta-analysis indicate that exercise intervention can improve the function of patients with ALS, increasing the distance of the WT and the maximum MEP. However, exercise intervention is not effective for MIP, FVC, PEF, and fatigue. Further subgroup analysis showed that resistance exercise was the most effective intervention for function in ALS patients, and aerobic exercise was the most effective intervention for FVC in ALS patients. The results of this study are similar to those of the systematic review and meta-analysis by Lui and Byl (38) and Meng et al. (21), both of which support the beneficial effects of moderate exercise in ALS patients. Quality grading of evidence in evidence-based medicine (39) suggests that meta-analysis based on RCTs is the highest level of evidence in clinical practice guidelines. In contrast, the study by Lui and Byl (38) was limited by the paucity of original studies and the inclusion of both animal models and human subjects for analysis, which somewhat reduced the accuracy of the findings. Therefore, researchers have also called for the need for a large number of RCTs to explore the effects of exercise interventions in ALS patients.
The results of the subgroup analysis showed that both aerobic and resistance exercise had a significant effect on function in ALS patients, with resistance exercise having the best effect. While Meng et al. (21) concluded that aerobic exercise had the best effect on ALS patients. Meng et al. (21) included only seven RCTs for combined effects tests and only one study with aerobic and resistance exercise interventions, respectively. Single-study comparisons may ignore the influence of demographic characteristics such as age, gender and duration of illness in the original study, creating a degree of uncertainty in the findings. Clawson et al. (40) explained why resistance training intervention is superior to aerobic exercise. This study evaluated the safety and tolerability of aerobic and resistance exercise in people with ALS and showed that both exercises are safe and tolerable for people with ALS. At the same time, the study noted that resistance exercise showed higher adherence and therefore more effective intervention time in the 24-week intervention, and therefore its intervention was most effective.
The motor neuron lesions caused by ALS lead to atrophy and functional decline of skeletal muscles, including respiratory muscles, making mobility difficult and often feeling fatigue, weakness and low energy (29, 34, 41). Respiratory exercise has been reported to have a beneficial effect on motor neuron disease (42). Clawson et al. (40) also demonstrated that aerobic and resistance exercise is safe and tolerable for ALS patients and does not increase fatigue in ALS patients. Therefore, a large number of studies have focused on investigating the effects of exercise interventions on physical and respiratory function in ALS patients, as well as analyzing the safety and tolerability of exercise by monitoring fatigue after exercise interventions. Meta- analysis results showed that exercise interventions helped to improve physical function and increase walking distances in ALS patients, with more prominent improvements in resistance exercise and aerobic exercise in particular. In addition, Meng et al. (21) showed that ALS patients did not further increase fatigue due to exercise interventions. Our study found that exercise intervention does not increase fatigue in ALS patients, further supporting that exercise therapy is feasible, safe, and well-tolerated by patients with ALS.
Fatigue is a common and potentially debilitating symptom in ALS patients, and subjective measures of fatigue are significantly and negatively correlated with patients’ quality of life (43, 44). Fatigue is mainly caused by ALS or its complications (respiratory failure, speech disorders, malnutrition, etc.) and is exacerbated by factors such as sleep disturbances, depression and anxiety, lack of activity, physical pain and mental disorders (26, 45). Studies related to exercise interventions in neurological disorders (46–48) have shown that moderate exercise can increase muscle mass and muscle strength, improve physiological function, enhance the ability to perform daily living activities and delay disease progression in patients. In addition, exercise interventions have positive effects on improving sleep disorders (49), depression and anxiety (50), and physical pain (51). Based on the above evidence, this study concludes that exercise interventions not only do not exacerbate fatigue in ALS patients, but may also significantly improve quality of life. The results are certainly encouraging and provide an evidence-based basis for promoting improvements in physical function through exercise therapy for ALS patients.
For ALS patients, normal respiratory function is reduced or even lost due to atrophy of the external intercostal muscles involved in breathing, as well as stiffness of the thoracic joints, which limits respiratory movements (52). Improving respiratory impairment in ALS patients through exercise can help improve the quality of survival, but the results of related studies are more controversial. A meta-analysis by Rahmati and Malakoutinia (20) showed that aerobic exercise, resistance exercise and combined exercise were not effective in improving respiratory function in ALS patients. A meta-analysis by Meng et al. (21) showed that exercise can improve FVC in ALS patients. In a meta-analysis by Ferreira et al. (42), which included both multiple sclerosis (MS) and ALS patients, a combined effects test showed that MEP and MIP were improved by respiratory muscle training in both MS and ALS patients, but the effect of the intervention was not significant for FVC in MS and ALS patients. The results of this study showed that exercise intervention helped to promote the improvement of MEP in ALS patients, but was not significant for MIP, FVC and PEF. In addition, for the first time, aerobic exercise was shown to be effective in promoting the improvement of FVC in ALS patients through subgroup analysis. Previous studies (53, 54) have shown that diaphragmatic pacing facilitated by exercise increases the amplitude of diaphragmatic movement, increases muscle thickness, improves ventilation and delays the decline in FVC. However, in ALS patients with restricted mobility, diaphragmatic pacing can cause venous thrombosis (53, 54). Eidenberger et al. (55) also showed that the evidence for improving respiratory function in ALS patients through respiratory muscle training is still insufficient. The relative paucity of studies included in this study and the large heterogeneity of some of the indicators also make it difficult to demonstrate the positive effects of exercise interventions on respiratory function in ALS patients.
Skeletal muscle is an important tissue involved in the development of ALS disease through the activation of retrograde signaling cascades that degrade motor neurons (56). The health and function of skeletal muscle is influenced by satellite cells, mitochondria and micoRNA (56). Based on the role of skeletal muscle in the development of ALS, it can be hypothesized that exercise improves muscle function and delays muscle decay by improving motor neurons. Metallothioneins (MTs) are strong scavengers of reactive oxygen species and have some neurotropic activity, so exercise may have a beneficial effect on spinal cord motor neurons in ALS patients due to the induction of MTs (52). Hashimoto et al. (57) showed that regular exercise on a treadmill increased the mRNA expression levels of MTs in mice and promoted the accumulation of MTs in the spinal cord, while promoting an enhanced immune response to MTs in astrocytes. Kassa et al. (58) also showed a potential neuroprotective effect of exercise in ALS patients, with exercise significantly improving microglia activation when damage to motor neurons was less severe. In addition, Lei and Huang (2) suggested that moderate exercise has a protective effect on motor neurons in ALS patients and can improve muscle function and disease progression in ALS patients through the expression of glucose transporter protein and glyceraldehyde-3-phosphate dehydrogenase.
Based on the key findings of this study, it is recommended that a comprehensive and effective treatment plan for ALS patients can be provided by integrating personalized exercise programs with professional multidisciplinary support. Firstly, ALS patients are advised to engage in moderate exercise and select the appropriate type of exercise according to their actual conditions, aiming to enhance their overall quality of life and physical capabilities. Secondly, when formulating an exercise plan, it is essential to consider the patient’s specific health status and functional level to ensure the safety and suitability of the exercises, to prevent exercise-related injuries, and to ensure that the exercise does not exacerbate the patient’s sense of fatigue. Lastly, this study encourages collaboration among multidisciplinary teams to provide education on exercise interventions to patients and their families, helping them understand the benefits and potential risks associated with exercise, and offering psychological support to assist patients in dealing with the emotional and psychological challenges posed by ALS.
However, this study still has the following limitations. Firstly, most of the included studies did not explicitly report the methods of randomization and measures of allocation concealment, and most of the studies had subject dropouts, presenting a potential risk of bias. Secondly, the research on ALS function was affected by publication bias and sensitivity issues. Thirdly, there were relatively few studies included regarding WT, MIP, MEP, and PEF, thus further exploration of the impact of exercise intervention on ALS is warranted. Finally, due to the limitations in the number of original studies, this study has only conducted subgroup analyses based on exercise type and has not yet analyzed other factors such as intervention duration, duration of each intervention session, and participant demographics. Therefore, it is not possible to provide more precise evidence at this stage. We hope that future studies will expand the pool of original research and further supplement the evidence for exercise interventions in ALS.
5 Conclusion
Exercise interventions can improve function, increase WT distance and MEP in ALS patients. Of these, resistance exercise was the most effective intervention for function in ALS patients, and aerobic exercise was the most effective intervention for FVC in ALS patients. This study recommends that a comprehensive and effective treatment plan for ALS patients can be provided by integrating personalized exercise programs with professional multidisciplinary support. However, due to the small number of included studies and possible issues of heterogeneity, risk of bias and sensitivity, the effects of the exercise intervention ALS need to be further explored.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
SR: Data curation, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft. XC: Conceptualization, Data curation, Investigation, Methodology, Software, Validation, Visualization, Writing – review & editing. SH: Data curation, Investigation, Methodology, Software, Validation, Visualization, Writing – review & editing. XF: Data curation, Methodology, Software, Supervision, Validation, Writing – review & editing. JZ: Investigation, Software, Visualization, Writing – review & editing. PS: Conceptualization, Data curation, Visualization, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2025.1499407/full#supplementary-material
References
1.
Guo YQ Li S Zhang HH Wu YM . Advance in pathogenesis of amyotrophic lateral sclerosis (review). Chin J Rehabil Theory Pract. (2017) 23:685–9.
2.
Lei Y Huang X . Research advances in exercise therapy for amyotrophic lateral sclerosis. Chin J Rehab Med. (2020) 35:238–43.
3.
Van Harten ACM Phatnani H Przedborski S . Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. (2021) 44:658–68. doi: 10.1016/j.tins.2021.04.008
4.
Cuffaro F Lamminpää I Niccolai E Amedei A . Nutritional and microbiota-based approaches in amyotrophic lateral sclerosis: from prevention to treatment. Nutrients. (2024) 17:102. doi: 10.3390/nu17010102
5.
Norris SP Likanje MFN Andrews JA . Amyotrophic lateral sclerosis:update on clinical management. Curr Opin Neurol. (2020) 33:641–8. doi: 10.1097/WCO.0000000000000864
6.
Oh J An J Park K Park Y . Psychosocial interventions for people with amyotrophic lateral sclerosis and motor neuron disease and their caregivers: a scoping review. BMC Nurs. (2024) 23:75. doi: 10.1186/s12912-024-01721-6
7.
Arti AK Singh M Arora S Dhiman S Satija S Singh TG . Pharmacotherapy of amyotrophic lateral sclerosis: an insight. Plant Arch. (2019) 19:1385–97.
8.
Tzeplaeff L Wilfling S Requardt MV Herdick M . Current state and future directions in the therapy of ALS. Cells. (2023) 12:1523. doi: 10.3390/cells12111523
9.
Gordon PH . Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs. (2011) 25:1–15. doi: 10.2165/11586000-000000000-00000
10.
Fenili G Scaricamazza S Ferri A Valle C Paronetto MP . Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression. Front Cell Dev Biol. (2024) 12:1421566. doi: 10.3389/fcell.2024.1421566
11.
Braga ACM Pinto A Pinto S de Carvalho M . The role of moderate aerobic exercise as determined by cardiopulmonary exercise testing in ALS. Neurol Res Int. (2018) 2018:1–10. doi: 10.1155/2018/8218697
12.
Wijesekera LC Nigel LP . Amyotrophic lateral sclerosis. Orphanet J Rare Dis. (2009) 4:1–22. doi: 10.1186/1750-1172-4-3
13.
Zarei S Carr K Reiley L Diaz K Guerra O Altamirano PF et al . A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. (2015) 6:171. doi: 10.4103/2152-7806.169561
14.
Kilmer DD . Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. (2002) 81:S121–6. doi: 10.1097/00002060-200211001-00013
15.
Zhao TT Ding SZ . ALS, skeletal muscle ageing and exercise. J Tianjin Univ Sport. (2006) 26:329–32.
16.
Aitkens SG McCrory MA Kilmer DD Bernauer EM . Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. (1993) 74:711–5. doi: 10.1016/0003-9993(93)90031-5
17.
Milner-Brown HS Miller RG . Muscle strengthening through high-resistance weight training in patients with neuromuscular disorders. Arch Phys Med Rehabil. (1988) 69:14–9. PMID:
18.
Francis K Bach JR DeLisa JA . Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil. (1999) 80:951–63. doi: 10.1016/S0003-9993(99)90089-8
19.
Zhu Y Xu Y Xuan R Huang J István B Fekete G et al . Mixed comparison of different exercise interventions for function, respiratory, fatigue, and quality of life in adults with amyotrophic lateral sclerosis: systematic review and network meta-analysis. Front Aging Neurosci. (2022) 14:919059. doi: 10.3389/fnagi.2022.919059
20.
Rahmati M Malakoutinia F . Aerobic, resistance and combined exercise training for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Physiotherapy. (2021) 113:12–28. doi: 10.1016/j.physio.2021.04.005
21.
Meng L Li X Li C Tsang RC Chen Y Ge Y et al . Effects of exercise in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Am J Phys Med Rehabil. (2020) 99:801–10. doi: 10.1097/PHM.0000000000001419
22.
Page MJ McKenzie JE Bossuyt PM Boutron I Hoffmann TC Mulrow CD et al . The PRISMA 2020 statement:an updated guideline for reporting systematic reviews. Int J Surg. (2021) 88:105906–16. doi: 10.1016/j.ijsu.2021.105906
23.
Costantino G Montano N Casazza G . When should we change our clinical practice based on the results of a clinical study? Searching for evidence: PICOS and PubMed. Intern Emerg Med. (2015) 10:525–7. doi: 10.1007/s11739-015-1225-5
24.
Cumpston M Li T Page MJ Chandler J Welch VA Higgins JP et al . Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. (2019) 10:ED000142. doi: 10.1002/14651858.ED000142
25.
Tarsilla M . Cochrane handbook for systematic reviews of interventions. J Multidiscip Eval. (2010) 6:142–8. doi: 10.56645/jmde.v6i14.284
26.
Drory VE Goltsman E Reznik JG Mosek A Korczyn AD . The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. (2001) 191:133–7. doi: 10.1016/S0022-510X(01)00610-4
27.
Kalron A Mahameed I Weiss I Rosengarten D Balmor GR Heching M et al . Effects of a 12-week combined aerobic and strength training program in ambulatory patients with amyotrophic lateral sclerosis: a randomized controlled trial. J Neurol. (2021) 268:1857–66. doi: 10.1007/s00415-020-10354-z
28.
Ferri A Lanfranconi F Corna G Bonazzi R Marchese S Magnoni A et al . Tailored exercise training counteracts muscle disuse and attenuates reductions in physical function in individuals with amyotrophic lateral sclerosis. Front Physiol. (2019) 10:1537. doi: 10.3389/fphys.2019.01537
29.
Cheah BC Boland RA Brodaty NE Zoing MC Jeffery SE McKenzie DK et al . INSPIRATIonAL–INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. (2009) 10:384–92. doi: 10.3109/17482960903082218
30.
Plowman EK Watts SA Tabor L Robison R Gaziano J Domer AS et al . Impact of expiratory strength training in amyotrophic lateral sclerosis. Muscle Nerve. (2016) 54:48–53. doi: 10.1002/mus.24990
31.
Bello-Haas VD Florence JM Kloos AD Scheirbecker J Lopate G Hayes SM et al . A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. (2007) 68:2003–7. doi: 10.1212/01.wnl.0000264418.92308.a4
32.
Merico A Cavinato M Gregorio C Lacatena A Gioia E Piccione F et al . Effects of combined endurance and resistance training in amyotrophic lateral sclerosis: a pilot, randomized, controlled study. Eur J Transl Myol. (2018) 28:7278. doi: 10.4081/ejtm.2018.7278
33.
Lunetta C Lizio A Sansone VA Cellotto NM Maestri E Bettinelli M et al . Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial. J Neurol. (2016) 263:52–60. doi: 10.1007/s00415-015-7924-z
34.
Pinto S Swash M de Carvalho M . Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. (2012) 13:33–43. doi: 10.3109/17482968.2011.626052
35.
Plowman EK Tabor-Gray L Rosado KM Vasilopoulos T Robison R Chapin JL et al . Impact of expiratory strength training in amyotrophic lateral sclerosis: results of a randomized, sham-controlled trial. Muscle Nerve. (2019) 59:40–6. doi: 10.1002/mus.26292
36.
van Groenestijn AC Schröder CD van Eijk RP Veldink JH Kruitwagen-van Reenen ET Groothuis JT et al . Aerobic exercise therapy in ambulatory patients with ALS: a randomized controlled trial. Neurorehabil Neural Repair. (2019) 33:153–64. doi: 10.1177/1545968319826051
37.
Shi P Li CY Sun JY . Effects of air pollutant exposure on lung function in exercisers: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. (2022) 26:462–70. doi: 10.26355/eurrev_202201_27871
38.
Lui AJ Byl NN . A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis. J Neurol Phys Ther. (2009) 33:68–87. doi: 10.1097/NPT.0b013e31819912d0
39.
Owens DK Lohr KN Atkins D Treadwell JR Reston JT Bass EB et al . AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions—agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. (2010) 63:513–23. doi: 10.1016/j.jclinepi.2009.03.009
40.
Clawson LL Cudkowicz M Krivickas L Brooks BR Sanjak M Allred P et al . A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. (2018) 19:250–8. doi: 10.1080/21678421.2017.1404108
41.
Lo Coco D La Bella V . Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol. (2012) 19:760–3. doi: 10.1111/j.1468-1331.2011.03637.x
42.
Ferreira GD Costa ACC Plentz RD Coronel CC Sbruzzi G . Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis. Physiotherapy. (2016) 102:221–8. doi: 10.1016/j.physio.2016.01.002
43.
Lou JS . Fatigue in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. (2008) 19:533–43. doi: 10.1016/j.pmr.2008.02.001
44.
McElhiney MC Rabkin JG Gordon PH Goetz R Mitsumoto H . Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. (2009) 80:1146–9. doi: 10.1136/jnnp.2008.163246
45.
Gibbons C Pagnini F Friede T Young CA . Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. (2018) 2018:CD011005–35. doi: 10.1002/14651858.CD011005.pub2
46.
Li QP Han BR Chen X . Summary of the best evidence for exercise in frail older people. Chin Nurs Res. (2020) 34:1681–7.
47.
Cabanas-Valdés R Bagur-Calafat C Girabent-Farrés M Caballero-Gómez FM Hernández-Valiño M Urrútia CG . The effect of additional core stability exercises on improving dynamic sitting balance and trunk control for subacute stroke patients: a randomized controlled trial. Clin Rehabil. (2016) 30:1024–33. doi: 10.1177/0269215515609414
48.
Liu Z Hsu FC Trombetti A King AC Liu CK Manini TM et al . Effect of 24-month physical activity on cognitive frailty and the role of inflammation: the LIFE randomized clinical trial. BMC Med. (2018) 16:185–10. doi: 10.1186/s12916-018-1174-8
49.
Gong MJ Tan SJ Sun YQ Wu Y Hu XF . Meta-analysis of sleep architecture in adults with exercise intervention sleep disorders. J Capit Uni Phys Educ Sports. (2021) 33:276–84.
50.
Wei DX . The relationship between tai chi exercise and mental health: a meta-analytic study. J Fujian Normal Univ. (2011) 27:111–6.
51.
Zhao YF Wo CN Yu MT . Current status of exercise interventions for physical pain during pregnancy. Chin J Modern Nurs. (2016) 22:2787–90.
52.
Shan SH Zhang YL Luo YM Li BH . Research advances in the care of patients with amyotrophic lateral sclerosis with respiratory impairment. Chin J Nurs. (2020) 55:1431–5.
53.
Onders RP Elmo M Kaplan C Katirji B Schilz R . Extended use of diaphragm pacing in patients with unilateral or bilateral diaphragm dysfunction: a new therapeutic option. Surgery. (2014) 156:776–86. doi: 10.1016/j.surg.2014.07.021
54.
Rezania K Gottlieb O Guralnick A Prachand V Sweitzer BJ Vigneswaran W et al . Venous thromboembolism after diaphragm pacing in amyotrophic lateral sclerosis. Muscle Nerve. (2014) 50:863–5. doi: 10.1002/mus.24420
55.
Eidenberger M Nowotny S . Inspiratory muscle training in patients with amyotrophic lateral sclerosis: a systematic review. NeuroRehabilitation. (2014) 35:349–61. doi: 10.3233/NRE-141148
56.
Tsitkanou S Della Gatta PA Russell AP . Skeletal muscle satellite cells, mitochondria, and MicroRNAs: their involvement in the pathogenesis of ALS. Front Physiol. (2016) 7:403–11. doi: 10.3389/fphys.2016.00403
57.
Hashimoto K Hayashi Y Inuzuka T Hozumi I . Exercise induces metallothioneins in mouse spinal cord. Neuroscience. (2009) 163:244–51. doi: 10.1016/j.neuroscience.2009.05.067
58.
Kassa RM Bonafede R Boschi F Bentivoglio M Mariotti R . Effect of physical exercise and anabolic steroid treatment on spinal motoneurons and surrounding glia of wild-type and ALS mice. Brain Res. (2017) 1657:269–78. doi: 10.1016/j.brainres.2016.12.029
Summary
Keywords
amyotrophic lateral sclerosis, physical function, respiratory function, exercise, meta-analysis
Citation
Ren S, Che X, Hu S, Feng X, Zhang J and Shi P (2025) The effect of exercise intervention on amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front. Neurol. 16:1499407. doi: 10.3389/fneur.2025.1499407
Received
24 September 2024
Accepted
15 April 2025
Published
21 May 2025
Volume
16 - 2025
Edited by
Wen Liu, University of Kansas Medical Center, United States
Reviewed by
Ramona Meanti, University of Milano Bicocca, Italy
Daragh Heitzman, Texas Neurology, United States
Ilya Bakulin, Research Center of Neurology, Russia
Updates
Copyright
© 2025 Ren, Che, Hu, Feng, Zhang and Shi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinrui Che, 33568616@qq.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.